IRVING NACHAMKIN, Dr.P.H., M.P.H.; CHRISTOPHER STOWELL, M.D., Ph.D.; DANIELA SKALINA, B.SC.; ANN M. JONES, B.S.; R. MARTIN HOOP II, B.S.; ROBERT M. SMIBERT, Ph.D.
An unusual species, Campylobacter laridis, belonging to the group of nalidixic acid resistant thermophilic Campylobacter species, was isolated from the blood of a 71-year-old man with multiple myeloma, hyperviscosity syndrome, and renal failure. The organism was first recognized in the laboratory by gram-stain reaction and resistance to nalidixic acid. The organism differs from C. jejuni and C. coli by its resistance to nalidixic acid, whereas anaerobic growth in the presence of trimethylamine N-oxide hydrochloride differentiates this organism from other Campylobacter species. Biochemical characterization and DNA homology studies confirmed the identity of this species as being C. laridis. To our knowledge, this is the first recorded case of bacteremia due to C. laridis in humans.
NACHAMKIN I, STOWELL C, SKALINA D, et al. Campylobacter laridis Causing Bacteremia in an Immunosuppressed Patient. Ann Intern Med. 1984;101:55–57. doi: https://doi.org/10.7326/0003-4819-101-1-55
Download citation file:
Published: Ann Intern Med. 1984;101(1):55-57.
Infectious Disease, Multi-Organ Failure and Sepsis, Pulmonary/Critical Care.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use